USRE30260E - 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-en]-3-ols - Google Patents

1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-en]-3-ols Download PDF

Info

Publication number
USRE30260E
USRE30260E US06/016,868 US1686879A USRE30260E US RE30260 E USRE30260 E US RE30260E US 1686879 A US1686879 A US 1686879A US RE30260 E USRE30260 E US RE30260E
Authority
US
United States
Prior art keywords
formula
compound
trimethyl
reaction
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US06/016,868
Inventor
Michael Rosenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoffmann La Roche Inc
Original Assignee
Hoffmann La Roche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/759,703 external-priority patent/US4098827A/en
Application filed by Hoffmann La Roche Inc filed Critical Hoffmann La Roche Inc
Priority to US06/016,868 priority Critical patent/USRE30260E/en
Application granted granted Critical
Publication of USRE30260E publication Critical patent/USRE30260E/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/02—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Definitions

  • halogen as used throughout this specification includes all four halogens, i.e. chlorine, fluorine, bromine and iodine.
  • lower alkyl as used herein designates a saturated aliphatic straight or branched chain hydrocarbon containing from 1 to 7 carbon atoms such as ethyl, methyl, isopropyl, etc.
  • lower alkoxy as used throughout the specification denotes lower alkoxy groups containing from 1 to 7 carbon atoms such as methoxy, ethoxy, isopropoxy, etc.
  • aryl designates mononuclear aromatic hydrocarbon groups such as phenyl, tolyl, which can be unsubstituted or substituted in one or more positions with a halogen, nitro, lower alkyl or lower alkoxy substituent and polynuclear aryl groups such as naphthyl, anthryl, phenanthryl, which can be unsubstituted or substituted with one or more of the aforementioned groups.
  • the preferred aryl groups are the substituted and unsubstituted mononuclear groups, particularly phenyl.
  • alkali metal includes all alkali metals such as sodium, potassium and lithium.
  • lower alkanol designates aliphatic unsaturated alcohols containing from 1 to 7 carbon atoms such as methanol, ethanol, isopropanol, n-butanol etc.
  • the compound of formula II is converted to the compound of formula V by reaction with a per-organic acid.
  • a per-organic acid any method of converting an unsaturated double bond to an epoxy bridge can be utilized.
  • per-organic acids are included per-acetic acid, per-benzoic acid, m-chloroper-benzoic acid etc. Any conventional per-organic acid can be utilized for this purpose. Any of the conventional reaction conditions utilized in forming epoxides can be used in this reaction.
  • the compound of formula V is converted to the compound of formula IV by treatment with alklai metal lower alkoxide.
  • Any conventional alklai metal lower alkoxide can be utilized such as sodium or potassium methoxide.
  • This reaction is carried out in a lower alkanol solvent.
  • the preferred solvents are methanol and ethanol.
  • any conventional lower alkanol can be utilized.
  • an inert organic solvent such as benzene, toluene, etc. can be used with the lower alkanol solvent.
  • any conventional inert organic solvent can, if desired, be incorporated in the lower alkanol solvent medium.
  • temperature and pressure are not critical and this reaction can be carried out at room temperature and atmospheric pressure. On the other hand, any temperature of from 10° C. to 100° C. can be utilized in carrying out this reaction.
  • the compound of formula IV can be prepared from retroionone, i.e. a compound of formula II-a via the following intermediate: ##STR6##
  • the compound of formula II-a is converted to the compound of formula VI by epoxidation via a per-organic acid in the manner described in connection with the reaction of a compound of formula II to a compound of formula V.
  • the compound of formula VI is converted to the compound of the formula IV by treating the compound of formula VI with an alklai metal lower alkoxide in a lower alkanol solvent in the same manner as described in connection with the conversion of a compound of the formula V to a compound of formula IV.
  • the compound of formula IV is treated with a vinylmetalic halide such as vinyl magnesium chloride under conditions conventional for reacting a ketone with an organo metallic halide.
  • a vinylmetalic halide such as vinyl magnesium chloride
  • the vinylmetalic halide can be utilized in amounts of 10 moles or more per mole of the compound of formula IV.
  • no beneficial results are achieved by utilizing such large an amount of the vinyl magnesium halide.
  • amounts of the vinyl metallic halide of greater than 10 moles per mole of the compound of formula IV are seldom utilized.
  • the compound of formula X can be prepared from the compound of formula IV by reacting the compound of formula IV with an alkali metal acetalide such as sodium acetalide. Any of the conditions conventional in reacting a ketone with an acetalide to form an addition product can be utilized in accordance with this invention.
  • the compound of formula X can be converted to the compound of formula IX via hydrogenation utilizing a Lindlar catalyst. Any conventional method of selectively reducing a triple bond to a double bond can be utilized in carrying out this reaction.
  • the compound of formula IX is converted to the compound of formula XI by treatment with a oxidizing agent.
  • a oxidizing agent Any conventional oxidizing agent can be utilized to affect this conversion.
  • maganese dioxide and the chromate oxidizing agents such as Jones reagent. Any of the conditions conventional in carrying out oxidation utilizing these reagents can be utilized in the conversion of a compound of formula X to a compound of formula XI.
  • the aluminum isopropoxide can be present in catalytic quantities, i.e. at least 0.1 mole percent based upon the moles of the compound of formula IX. If desired, the aluminum isopropoxide can be present in an amount of 100 mole percent based upon the compound of formula IX. In fact, any excess of the aluminum isopropoxide will not deleteriously affect this reaction. However, for economics it is generally preferred to utilize the aluminum isopropoxide in an amount of from 0.1 mole percent to 100 mole percent based upon the weight of the compound of formula IX.
  • the oxidation with aluminum isopropoxide and acetone can be carried out in the presence of an inert organic solvent such as methylene chloride, benzene and toluene.
  • an inert organic solvent such as methylene chloride, benzene and toluene.
  • any inert organic solvent can, if desired, be utilized in a mixture with acetone.
  • this reaction is carried out at the reflux temperature of the reaction medium.
  • the compound of formula XI is converted to the compound of formula XII by treating the compound of formula XI with a phosphorous trihalide.
  • this reaction is carried out in an inert organic solvent. Any conventional inert organic solvent can be utilized to carry out this reaction.
  • the preferred solvents are the ether solvents such as diethyl ether, tetrahydrofuran, etc.
  • temperature and pressure are not critical and this reaction can be carried out at room temperature and atmospheric pressure. Generally it is preferred to carry out this reaction at a temperature of from 10° C. to 100° C.
  • the compound of formula XII is converted to the compound of formula X by reacting the compound of formula XII with a phosphine of the formula ##STR9## wherein R 1 , R 2 and R 3 are as above.
  • This reaction is generally carried out in an inert organic solvent. Any conventional inert organic solvent can be utilized to carry out this reaction. Among the preferred solvents are the ether solvents and the hydrocarbon solvents such as benzene, toluene, etc. In carrying out this reaction, temperature and pressure are not critical and generally this reaction can be carried out at room temperature and atmospheric pressure. Generally, it is preferred to carry out this reaction by heating the reaction medium to the reflux temperature.
  • the compound of formula X can be directly prepared from the compound of formula XI by treating the compound of formula XI with the hydrohalic acid salt of the phosphine of formula XIII.
  • hydrohalic acid salts triphenylphosphine hydrobromide is preferred.
  • This reaction is generally carried out in a inert organic solvent. Any conventional inert organic solvent can be utilized for this purpose.
  • the halogenated hydrocarbon solvents such as dichloromethane, methylene, chloride, etc.
  • temperature and pressure are not critical and this reaction can be carried out at room temperature and atmospheric pressure. If desired, higher or lower temperatures can be utilized.
  • the compound of formula I is formed from the compound of formula X by reacting the compound of formula X with a compound of the formula: ##STR10## via a Wittig reaction.
  • This reaction is carried out utilizing conditions that are conventional in Wittig type reactions. In this reaction, two moles of the compound of formula X are reacted per mole of the compound of formula XX.
  • hydroxyketone 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexen-1-yl)-3-methyl-penta-1,4-dien-3-ol (4 g) dissolved in diethyl ether (40 ml) was cooled to -20° and treated with a solution of phosphorous tribromide in diethyl ether (1 mole. equiv PBr 3 ; 80 ml) and then warmed to RT.
  • Example 6 The bromide of Example 6 was added to triphenylphosphine (4.4 g) in benzene (30 ml) and heated at reflux for 1 hour. The mixture was then cooled to RT treated with diethyl ether (50 ml) and filtered to yield the 5-(2,6,6-trimethyl-3-oxo-cyclohexen-1-yl)-3-methyl-2,3-pentadiene-1-triphenylphosphonium bromide as a white powder (6.6 g).
  • Retro-ionone (1.9 g) was added to a solution of m-chloroperbenzoic acid (2.2 g) dissolved in dichloromethane. This resulted in an exothermic reaction ( ⁇ 40°). After cooling, the mixture was washed with an aqueous sodium carbonate solution dried over MgSO 4 and taken to dryness to yield the epoxide, the 1-(2,6,6-Trimethyl-2,3-epoxy-1-cyclohexylidene)-buten-2-one. This epoxide ( ⁇ 2 g) was dissolved in a solution of methanolic sodium methoxide (1.4 Molar; 20 ml) and left at RT for 1/2 hour (instant color change and probably complete reaction). Dilution with ether followed by a brine washing yielded 1-(2,6,6,-trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-oxo-1-butene, upon chromatography over silica gel.
  • This crude diol (216.9 g) in a mixture of acetone and dichloromethane (1:1; 2000 ml) containing aluminum isopropoxide (400 g) was heated at reflux for 5 hours (tlc; 1:1 benzene/ethyl acetate), cooled, treated with more dichloromethane (1000 ml) and then acidified with aqueous sulfuric acid (2 N; 2000 ml) with ice cooling.
  • the hydroxyketone 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexene-1-yl)-3-methyl-penta-1,4-diene-3-ol (136.6 g) was dissolved in diethyl ether (1000 ml) cooled to -20° and exposed to a solution of phosphorous tribromide (50 ml) in ether (250 ml) and then stirred for 1 hour at RT. After this period, the mixture was cooled to 5°, treated with water (500 ml; care) and the ether layer was then washed well with water, saturated aqueous sodium bicarbonate solution, brine and then dried over anhydrous magnesium sulfate. (All the aqueous extracts were back-washed with more diethyl ether.)
  • hydroxyketone 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexene-1-yl)-3-methyl-penta-1,4-diene-3-ol (10.7 g) dissolved in dichloromethane (25 ml) was treated with triphenylphosphine hydrobromide (14.4 g; 0.9 mol equiv) in more dichloromethane (50 ml) and left overnight at RT (the reaction is exothermic and complete in ca 1 hours). Most of the solvents were then evaporated off and thick syrupy residue was digested with diethyl ether and filtered.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A total synthesis of canthaxanthin, a known food coloring agent from alpha or retro ionone.

Description

CROSS REFERENCE TO RELATED APPLICATION
This application is related to Ser. No. 585,224, filed Jul. 9, 1975, Rosenberger et al. now U.S. Pat. No. 4,006,186.
SUMMARY OF INVENTION
In accordance with this invention, a method is provided for synthesizing canthaxanthin which has the formula; ##STR1## from either α-ionone which has the formula ##STR2## or retroionone ##STR3##
DETAILED DESCRIPTION
The term halogen as used throughout this specification includes all four halogens, i.e. chlorine, fluorine, bromine and iodine. The term "lower alkyl" as used herein designates a saturated aliphatic straight or branched chain hydrocarbon containing from 1 to 7 carbon atoms such as ethyl, methyl, isopropyl, etc. The term "lower alkoxy" as used throughout the specification denotes lower alkoxy groups containing from 1 to 7 carbon atoms such as methoxy, ethoxy, isopropoxy, etc.
As used herein, the term "aryl" designates mononuclear aromatic hydrocarbon groups such as phenyl, tolyl, which can be unsubstituted or substituted in one or more positions with a halogen, nitro, lower alkyl or lower alkoxy substituent and polynuclear aryl groups such as naphthyl, anthryl, phenanthryl, which can be unsubstituted or substituted with one or more of the aforementioned groups. The preferred aryl groups are the substituted and unsubstituted mononuclear groups, particularly phenyl. The term "alkali metal" includes all alkali metals such as sodium, potassium and lithium. The term "lower alkanol" designates aliphatic unsaturated alcohols containing from 1 to 7 carbon atoms such as methanol, ethanol, isopropanol, n-butanol etc.
In the first steps in the production of the compound of formula I in accordance with this invention, the compound of formula II is converted to a compound of formula ##STR4## via the following intermediate: ##STR5##
The compound of formula II is converted to the compound of formula V by reaction with a per-organic acid. In this procedure, any method of converting an unsaturated double bond to an epoxy bridge can be utilized. Among the preferred per-organic acids are included per-acetic acid, per-benzoic acid, m-chloroper-benzoic acid etc. Any conventional per-organic acid can be utilized for this purpose. Any of the conventional reaction conditions utilized in forming epoxides can be used in this reaction.
The compound of formula V is converted to the compound of formula IV by treatment with alklai metal lower alkoxide. Any conventional alklai metal lower alkoxide can be utilized such as sodium or potassium methoxide. This reaction is carried out in a lower alkanol solvent. Among the preferred solvents are methanol and ethanol. However, any conventional lower alkanol can be utilized. If desired, an inert organic solvent such as benzene, toluene, etc. can be used with the lower alkanol solvent. In this regard, any conventional inert organic solvent can, if desired, be incorporated in the lower alkanol solvent medium. In carrying out this reaction, temperature and pressure are not critical and this reaction can be carried out at room temperature and atmospheric pressure. On the other hand, any temperature of from 10° C. to 100° C. can be utilized in carrying out this reaction.
On the other hand, the compound of formula IV can be prepared from retroionone, i.e. a compound of formula II-a via the following intermediate: ##STR6##
The compound of formula II-a is converted to the compound of formula VI by epoxidation via a per-organic acid in the manner described in connection with the reaction of a compound of formula II to a compound of formula V. The compound of formula VI is converted to the compound of the formula IV by treating the compound of formula VI with an alklai metal lower alkoxide in a lower alkanol solvent in the same manner as described in connection with the conversion of a compound of the formula V to a compound of formula IV.
The compound of formula IV is converted in the next series of steps to a phosphonium salt of the formula: ##STR7## wherein R1, R2 and R3 are aryl or lower alkyl; and X is halogen.
In this conversion, the following intermediates are formed ##STR8## where X is as above.
In the conversion of a compound of formula IV to a compound of formula IX, the compound of formula IV is treated with a vinylmetalic halide such as vinyl magnesium chloride under conditions conventional for reacting a ketone with an organo metallic halide. In carrying out this reaction, it is generally preferred to utilize at least 2 moles of the vinyl metallic halide per mole of the compound of formula IV. If desired, the vinylmetalic halide can be utilized in amounts of 10 moles or more per mole of the compound of formula IV. However, no beneficial results are achieved by utilizing such large an amount of the vinyl magnesium halide. Furthermore, due to the cost of utilizing such large amounts, amounts of the vinyl metallic halide of greater than 10 moles per mole of the compound of formula IV are seldom utilized.
The compound of formula X can be prepared from the compound of formula IV by reacting the compound of formula IV with an alkali metal acetalide such as sodium acetalide. Any of the conditions conventional in reacting a ketone with an acetalide to form an addition product can be utilized in accordance with this invention. The compound of formula X can be converted to the compound of formula IX via hydrogenation utilizing a Lindlar catalyst. Any conventional method of selectively reducing a triple bond to a double bond can be utilized in carrying out this reaction.
The compound of formula IX is converted to the compound of formula XI by treatment with a oxidizing agent. Any conventional oxidizing agent can be utilized to affect this conversion. Among the preferred oxidizing agents are included maganese dioxide and the chromate oxidizing agents such as Jones reagent. Any of the conditions conventional in carrying out oxidation utilizing these reagents can be utilized in the conversion of a compound of formula X to a compound of formula XI.
Among the preferred methods for carrying out the conversion of a compound of formula X to a compound of formula XI is by oxidation with aluminum isopropoxide in the presence of acetone. It is through this method that the compound of formula XI is produced in high yields from the compound of formula X. In carrying out this reaction, the aluminum isopropoxide can be present in catalytic quantities, i.e. at least 0.1 mole percent based upon the moles of the compound of formula IX. If desired, the aluminum isopropoxide can be present in an amount of 100 mole percent based upon the compound of formula IX. In fact, any excess of the aluminum isopropoxide will not deleteriously affect this reaction. However, for economics it is generally preferred to utilize the aluminum isopropoxide in an amount of from 0.1 mole percent to 100 mole percent based upon the weight of the compound of formula IX.
Generally, the oxidation with aluminum isopropoxide and acetone can be carried out in the presence of an inert organic solvent such as methylene chloride, benzene and toluene. In fact, any inert organic solvent can, if desired, be utilized in a mixture with acetone. Generally, this reaction is carried out at the reflux temperature of the reaction medium.
The compound of formula XI is converted to the compound of formula XII by treating the compound of formula XI with a phosphorous trihalide. Generally, this reaction is carried out in an inert organic solvent. Any conventional inert organic solvent can be utilized to carry out this reaction. Among the preferred solvents are the ether solvents such as diethyl ether, tetrahydrofuran, etc. In carrying out this reaction, temperature and pressure are not critical and this reaction can be carried out at room temperature and atmospheric pressure. Generally it is preferred to carry out this reaction at a temperature of from 10° C. to 100° C.
The compound of formula XII is converted to the compound of formula X by reacting the compound of formula XII with a phosphine of the formula ##STR9## wherein R1, R2 and R3 are as above.
This reaction is generally carried out in an inert organic solvent. Any conventional inert organic solvent can be utilized to carry out this reaction. Among the preferred solvents are the ether solvents and the hydrocarbon solvents such as benzene, toluene, etc. In carrying out this reaction, temperature and pressure are not critical and generally this reaction can be carried out at room temperature and atmospheric pressure. Generally, it is preferred to carry out this reaction by heating the reaction medium to the reflux temperature.
In accordance with another embodiment of this invention, the compound of formula X can be directly prepared from the compound of formula XI by treating the compound of formula XI with the hydrohalic acid salt of the phosphine of formula XIII. Among the hydrohalic acid salts, triphenylphosphine hydrobromide is preferred. This reaction is generally carried out in a inert organic solvent. Any conventional inert organic solvent can be utilized for this purpose. Among the preferred solvents are included the halogenated hydrocarbon solvents such as dichloromethane, methylene, chloride, etc. In carrying out this reaction, temperature and pressure are not critical and this reaction can be carried out at room temperature and atmospheric pressure. If desired, higher or lower temperatures can be utilized.
The compound of formula I is formed from the compound of formula X by reacting the compound of formula X with a compound of the formula: ##STR10## via a Wittig reaction.
This reaction is carried out utilizing conditions that are conventional in Wittig type reactions. In this reaction, two moles of the compound of formula X are reacted per mole of the compound of formula XX.
The invention will be more fully understood from the specific examples which follow. These examples are intended to illustrate the invention and are not to be construed as limitative thereof. In the Examples, the temperatures utilized are in degrees centigrade. When a mixture of organic liquids are utilized, the ratios set forth in the Examples is a volume ratio unless indicated otherwise.
EXAMPLE 1 4-(2,6,6-Trimethyl-2,3-epoxy-cyclohex-1-yl)-3-buten-2-one
A solution of m-chloro perbenzoic acid (23 g; 133 mol) in dichloromethane (200 ml) was cooled to 10° and treated with α-ionone (20.8 g; 92% purity) with cooling. After the complete addition, the mixture was stirred a further 20 min at room temperature (RT) and then cooled to 10° (t.l.c. analysis showed no α-ionone; 3:1 benzene/ethylacetate system).
To the cooled solution was added an aqueous solution of sodium hydroxide (100 ml; 2 N) and the phases were then separated and the organic layer was washed with more base (100 ml; 2 N), brine and dried over magnesium sulfate (MgSO4).
Removal of the solids and distillation of the filtrate yielded pure 4-(2,6,6-Trimethyl-2,3-epoxy-cyclohex-1-yl)-3-buten-2-one (19.51 g); bp 113°-120° (0.5 mm) (4 inch vacuum jacketed vigreaux column).
EXAMPLE 2 Oxidation of α-ionone with peracetic acid
A mixture of peracetic acid (40%; 54 g), anhydrous sodium acetate (10 g) and dichloromethane (200 ml) was treated at RT with α-ionone (30 g; 94% purity) and the temperature was kept at RT with ice cooling. After the exotherm had subsided, the reaction mixture was stirred for a further 2 hours, treated with benzene (300 ml) and washed with a aqueous sodium bicarbonate solution (saturated), aqueous potassium metabisulfite and dried over Mgg SO4.
Removal of the solids and concentrations to dryness yielded a 100% material balance of excellent quality 4-(2,6,6-Trimethyl-2,3-epoxy-cyclohex-1-yl)-3-buten-2-one (by pmr analysis).
EXAMPLE 3 (2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-oxo-trans-1-butene
The α-ionone epoxide 4-(2,6,6-Trimethyl-2,3-epoxycyclohex-1-yl)-3-buten-2-one (10 g) was dissolved in methanol, treated with a solution of sodium methoxide in methanol (1.41 Molar; 5 ml) and heated at reflux for 2 hours (tlc, 3:1 benzene/ethylacetate, showed virtually complete conversion to product). After cooling to RT, diethyl ether (300 ml) was added and the mixture was washed with water and concentrated to dryness to yield the crude product (9 g). This material was distilled through a short vigreaux column (3 cm) to yield pure (2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-oxo-trans-1-butene (5.95 g) bp 130°-140° (0.2-0.5 mm).
EXAMPLE 4 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexene-1-yl)-3-methyl-penta-1,4-dien-3-ol
A solution of vinylmagnesium chloride in tetrahydrofuran (THF; 190 ml; 2.3 Molar) was cooled to 0° and treated with a solution of the hydroxyketone, 4-(2,6,6-trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-oxo-trans-1-butene (17 g; distilled material) dissolved in THF (150 ml). After complete addition the reaction mixture was stirred an additional 1 hour at RT and then quenched with an aqueous solution of ammonium chloride (10% by weight; 200 ml).
Extraction with diethyl ether and concentration yielded the crude diol, 1-(2,6,6-trimethyl-3-hydroxy-1-cyclohexene-1-yl)-3-methyl-penta-1,4-diene-3-ol (30 g) as a thick oil.
A sample of this material (1 g) was chromatographed on silica gel (100 g) and yielded analytically pure 1-(2,6,6-trimethyl-3-hydroxy-1-cyclohexene-1-yl)-methyl-penta-1,4-diene-3-ol on elution with an ethylacetatebenzene mixture (1:1).
EXAMPLE 5 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexen-1-yl)-3-methyl-penta-1,4-dien-3-ol
The crude diol 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexene-1-yl)-3-methyl-penta-1,4-diene-3-ol (25 g) was dissolved in a mixture of dichloromethane (250 ml) and acetone (250 ml) and then heated at reflux for 16 hours with aluminum isopropoxide (50 g).
After cooling to RT the mixture was washed with dilute aqueous sulfuric acid (1 N) and dried over MgSO4.
Removal of the solids and solvents yielded the 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexen-1-yl)-3-methyl-penta-1,4-dien-3-ol as a crude product (30 g).
Chromatography on silica gel (27 g product on 400 g) yielded the ketoalcohol 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexen-1-yl)-3-methyl-penta-1,4-dien-3-ol (9.8 g) on elution with an ether/hexane mixture (80%).
EXAMPLE 6 Phosphonium Salt
The hydroxyketone 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexen-1-yl)-3-methyl-penta-1,4-dien-3-ol (4 g) dissolved in diethyl ether (40 ml) was cooled to -20° and treated with a solution of phosphorous tribromide in diethyl ether (1 mole. equiv PBr3 ; 80 ml) and then warmed to RT. After stirring a further 1 hour at RT (while tlc indicated the rapid disappearance of starting material the yields of bromide were low if the reaction is worked up too soon) the mixture was cooled to 5° and carefully quenched with water (100 ml) and extracted with more ether.
The combined ether extracts were washed with saturated aqueous sodium bicarbonate solution, brine and dried over MgSO4. Removal of the solids and concentration in vacuo yielded the 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexen-1-yl)-3-methyl-5-bromo-penta-1,3-diene (4.15 g).
EXAMPLE 7
The bromide of Example 6 was added to triphenylphosphine (4.4 g) in benzene (30 ml) and heated at reflux for 1 hour. The mixture was then cooled to RT treated with diethyl ether (50 ml) and filtered to yield the 5-(2,6,6-trimethyl-3-oxo-cyclohexen-1-yl)-3-methyl-2,3-pentadiene-1-triphenylphosphonium bromide as a white powder (6.6 g).
EXAMPLE 8
Retro-ionone (1.9 g) was added to a solution of m-chloroperbenzoic acid (2.2 g) dissolved in dichloromethane. This resulted in an exothermic reaction (˜40°). After cooling, the mixture was washed with an aqueous sodium carbonate solution dried over MgSO4 and taken to dryness to yield the epoxide, the 1-(2,6,6-Trimethyl-2,3-epoxy-1-cyclohexylidene)-buten-2-one. This epoxide (˜2 g) was dissolved in a solution of methanolic sodium methoxide (1.4 Molar; 20 ml) and left at RT for 1/2 hour (instant color change and probably complete reaction). Dilution with ether followed by a brine washing yielded 1-(2,6,6,-trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-oxo-1-butene, upon chromatography over silica gel.
EXAMPLE 9 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexen-1-yl)-3-methyl-penta-1,4-dien-3-ol
A solution of α-ionone (202.5 g; 94% by glc) in dichloromethane (1100 ml) containing anhydrous sodium acetate (50 g) was cooled to 15° and treated over 30 min with peracetic acid (250 ml; 40% in acetic acid; from FMC).
After stirring for 21/2 hours the reaction was no longer exothermic and the reaction mixture was stirred a further 3 hours at RT and then washed with water (2×500 ml), aqueous potassium metabisulfite solution (10%; 2×250 ml), sodium hydroxide solution (2 M; 400 ml) and water (400 ml). Removal of the solvents gave the 4-(2,6,6-trimethyl-2,3-epoxy-cyclohex-1-yl)-3-buten-2-one having a nmr spectrum virtually identical with a distilled sample.
This material was dissolved in methanol (800 ml), treated with a methanolic solution of sodium methoxide (100 ml; 1.4 M) and heated at reflux for 3 hours (tlc; 1:1 benzene/ethylacetate). After cooling to RT acetic acid (9 ml) was added, followed by water (180 ml) and the mixture was then extracted with hexane saturated with an 80% methanol/water mixture (500 & 2×250 ml). The hexane extracts were back extracted with an 80% methanol/water mixture (saturated with hexane) and the combined methanolic extracts were concentrated and re-extracted into ether. Removal of the ether gave the desired hydroxyketone 4-(2,2,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-oxo-trans-1-butene; (204.1 g) as an oil.
This crude product was dissolved in tetrahydrofuran THF; 1000 ml) cooled to -30° and then treated with a freshly prepared solution of vinylmagnesium chloride (680 ml; 3.3 M) in THF. The first portion (350 ml) was added between -30° and -10° followed by the remainder at -10°→0°. At this stage the mixture is difficult to stir and after a further 30 min at 10° diethyl ether (1000 ml) was added (to help the stirring) followed by a saturated solution of ammonium chloride (250 ml). The solids were filtered off, washed well with more ether and the combined filtrates were concentrated to yield the diol, 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexene-1-yl)-3-methyl-penta-1,4-diene-3-ol (231.8 g).
This crude diol (216.9 g) in a mixture of acetone and dichloromethane (1:1; 2000 ml) containing aluminum isopropoxide (400 g) was heated at reflux for 5 hours (tlc; 1:1 benzene/ethyl acetate), cooled, treated with more dichloromethane (1000 ml) and then acidified with aqueous sulfuric acid (2 N; 2000 ml) with ice cooling. The aqueous layer was back-washed with more dichloromethane (4×500 ml) and the combined extracts were then concentrated to ca 600 ml, dried over magnesium sulfate and then taken to dryness to yield a crude hydroxyketone, 1-(2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-3-methyl-penta-1,4-dien-3-ol (219.5 g).
EXAMPLE 10 Phosphonium Salt
The hydroxyketone 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexene-1-yl)-3-methyl-penta-1,4-diene-3-ol (136.6 g) was dissolved in diethyl ether (1000 ml) cooled to -20° and exposed to a solution of phosphorous tribromide (50 ml) in ether (250 ml) and then stirred for 1 hour at RT. After this period, the mixture was cooled to 5°, treated with water (500 ml; care) and the ether layer was then washed well with water, saturated aqueous sodium bicarbonate solution, brine and then dried over anhydrous magnesium sulfate. (All the aqueous extracts were back-washed with more diethyl ether.)
Removal of the solvents yielded the crude bromide (147 g) 1-(2,6,6-Trimethyl-3-oxo-1-cyclohexene-1-yl)-3-methyl-5-bromo-penta-1,3-diene, which was dissolved in benzene (1000 ml) containing triphenylphosphine (144 g) and heated at reflux for 11/2 hours. The mixture, was then cooled to RT, treated with diethyl ether (1000 ml) and stirred for ca 1 hour (the thick syrup slowly yields a granular product).
The solids were filtered off and washed with more diethyl ether and dried to yield the crude salt (296.7 g) which was a mixture of at least two salts (tlc; n-butyl acetate/formic acid/water; 80:18:2). This material (269.3 g) was dissolved in dichloromethane (2500 ml) and treated with diethyl ether (125 ml) and filtered. The filtrate was concentrated to dryness to yield 5-(2,6,6-Trimethyl-3-oxo-cyclohexen-1-yl)-2-methyl-2,3-pentadiene-1-triphenylphonium bromide (38.5 g) mp 261°-63°.
EXAMPLE 11
The hydroxyketone 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexene-1-yl)-3-methyl-penta-1,4-diene-3-ol (10.7 g) dissolved in dichloromethane (25 ml) was treated with triphenylphosphine hydrobromide (14.4 g; 0.9 mol equiv) in more dichloromethane (50 ml) and left overnight at RT (the reaction is exothermic and complete in ca 1 hours). Most of the solvents were then evaporated off and thick syrupy residue was digested with diethyl ether and filtered. The residue was then dried to give 5-(2,6,6-Trimethyl-3-oxo-cyclohexen-1-yl)-3-methyl-2,4-pentadiene-1-triphenylphosphonium bromide as solid (23.5 g) which assayed for ca 84% pure by nmr analysis.
EXAMPLE 12 Canthaxanthin
A solution of the pure trans dialdehyde-2,7-dimethyl-2,4,6-octatriene-1,8-dial (1.64 g) and the phosphonium salt, 5-(2,6,6-Trimethyl-3-oxo-cyclohexen-1-yl)-3-methyl-2,4-pentadiene-1-triphenylphosphonium bromide (14.6 g) in dichloromethane (50 ml) was cooled to -10° and treated over 15 min with a methanolic solution of sodium methoxide (3.6 Molar; 6.7 ml) and then stirred a further 30 min at -10°→-5°.
After this time the mixture was washed with water and the solvents were removed to give the crude product and triphenylphosphine oxide (14.5 g). This material was chromatographed on silica gel (200 g) to yield the carotenoid fraction (6.47 g) on elution with benzene/ethyl acetate mixtures (tlc; 10% ether/dichloromethane). Crystallization from dichloromethane/methanol gave canthaxanthin (2.76 g). The mother liquors were concentrated to dryness, dissolved in hot isopropanol and cooled to RT. Filtering of the solvents gave a further amount of canthaxanthin (0.91 g). The filtrate from this crystallization was concentrated and the residue was then heated at reflux in water (100 ml) for 18 hours. Crystallization of the residue from a dichloromethane/methanol mixture gave a further quantity of canthaxanthin (1.02 g).

Claims (3)

I claim: .[.
1. A compound of the formula: ##STR11## where the dotted bond is hydrogenated..]. .[.
2. The compound of claim 1 wherein said compound is 1-(2,6,6-trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene-3-ol..]. .Iadd.
3. A compound of the formula: ##STR12## .Iaddend.
US06/016,868 1977-01-17 1979-03-02 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-en]-3-ols Expired - Lifetime USRE30260E (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/016,868 USRE30260E (en) 1977-01-17 1979-03-02 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-en]-3-ols

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/759,703 US4098827A (en) 1977-01-17 1977-01-17 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-EN]-3-ols
US06/016,868 USRE30260E (en) 1977-01-17 1979-03-02 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-en]-3-ols

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US05/759,703 Reissue US4098827A (en) 1977-01-17 1977-01-17 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-EN]-3-ols

Publications (1)

Publication Number Publication Date
USRE30260E true USRE30260E (en) 1980-04-22

Family

ID=26689166

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/016,868 Expired - Lifetime USRE30260E (en) 1977-01-17 1979-03-02 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-en]-3-ols

Country Status (1)

Country Link
US (1) USRE30260E (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2726269A (en) * 1955-12-06 Method of making acetylenic carbinols
US2819298A (en) * 1955-07-22 1958-01-07 Hoffmann La Roche Process for the manufacture of carotenoids
DE2037935A1 (en) 1969-08-01 1971-02-11 F Hoffmann La Roche & Co AG, Basel (Schweiz) Process for the production of polyene compounds
US3932485A (en) * 1974-08-28 1976-01-13 Hoffmann-La Roche Inc. Improved preparation of Wittig salt of vinyl β-ionol
US3947498A (en) * 1973-04-23 1976-03-30 Scm Corporation Vitamin A intermediates
US4000198A (en) * 1975-06-09 1976-12-28 Hoffmann-La Roche Inc. Hydroxy-acetylene-substituted cyclohexenone

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2726269A (en) * 1955-12-06 Method of making acetylenic carbinols
US2819298A (en) * 1955-07-22 1958-01-07 Hoffmann La Roche Process for the manufacture of carotenoids
DE2037935A1 (en) 1969-08-01 1971-02-11 F Hoffmann La Roche & Co AG, Basel (Schweiz) Process for the production of polyene compounds
US3947498A (en) * 1973-04-23 1976-03-30 Scm Corporation Vitamin A intermediates
US3932485A (en) * 1974-08-28 1976-01-13 Hoffmann-La Roche Inc. Improved preparation of Wittig salt of vinyl β-ionol
US4000198A (en) * 1975-06-09 1976-12-28 Hoffmann-La Roche Inc. Hydroxy-acetylene-substituted cyclohexenone

Similar Documents

Publication Publication Date Title
US4098827A (en) 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-EN]-3-ols
US4105855A (en) Manufacture of symmetrical carotenoids
US3975445A (en) Novel polyene compounds and process therefor
GB2114570A (en) Chemical compounds
US6204414B1 (en) Intermediate compound (5-[2-hydroxy-5-(1-hydroxy-1-methylethyl)-2-methyl-cyclopentyl]-3-methyl-penta-2,4-dienyl) triphenylphos-phosphonium salt, for making metabolites of lycopene
US4153615A (en) Method of producing coloring agents
EP0022162A1 (en) Process for producing disubstituted 4-hydroxycyclopentenones; monosubstituted cyclopentendiones and 4-hydroxycyclopentenones
US3015680A (en) Process for the manufacture of carotene compounds
US4000131A (en) Process for preparing epoxide-cyclohexyl compound and resultant compound
US2842599A (en) Carotenoids and intermediates therefor
US3277147A (en) Lower alkyl esters of beta-cyclocitrylidene fluoroacetic acid and beta-ionylidene fluoroacetic acid
US4157345A (en) 2,6,6-Trimethyl-3-alkoxy-cyclohex-2-en-1-ones
USRE30260E (en) 1-(2,6,6-Trimethyl-3-hydroxy-1-cyclohexen-1-yl)-3-methyl-penta-1,4-diene[or 1-yn-4-en]-3-ols
US4088689A (en) Cyclohexenone phosphonium salts
US4270003A (en) Hydroquinone derivatives and preparation thereof
US4045476A (en) 1-(2,6,6-Trimethyl-3-hydroxy or lower alkanoyloxycyclohexen-1-yl)-3-methyl-4-penten-1-yn-3-ol compound
US2809216A (en) Polyene aldehyde and alcohols
JPH03240752A (en) 1-halo-4,6,10-hexadecatriene compound and production thereof
US4543417A (en) ω,ω-Diacyloxy-2,6-dimethyl-octatrienoates and -octatrienals, their preparation and their use for the synthesis of terpene compounds
US4323711A (en) Process for producing cyclohexenes
US3624105A (en) Method for synthesizing rhodoxanthin
US4153805A (en) Preparation of food coloring agents
US3281440A (en) Fluorinated vitamin a compounds
US4107181A (en) Useful prostaglandin intermediates
US2849495A (en) Preparation of 3, 4-dehydro-beta-carotene